Khondrion announces grant of patents in the US and Europe for its lead candidate sonlicromanol, covering the anti-inflammatory effect on mPGES-1

Khondrion United Kingdom United States of America Netherlands

View original content:https://www.prnewswire.co.uk/news-releases/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1-301973250.html